当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3810103
自主品牌
已选条件
-
T8482Ripretinibc-Kit,Inhibitor,DCC2618,Vascular endothelial growth factor receptor,CD135,CD117,Platelet-d
Ripretinib is an orally bioavailable inhibitor of KIT and PDGFRA.
价 格：￥电议型 号：T8482产 地：中国大陆
-
T4332c-Kit-IN-1PDGFR inhibitor 1；DCC-2618
DCC-2618 is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).
价 格：￥电议型 号：T4332产 地：中国大陆
-
T20760Benzidine orangeDCC 1802；Oralith Orange PG；DCC1802；Polymo Orange GR；DCC-1802；颜料橙13
Benzidine orange shows mutagenic and carcinogenic activity.
价 格：￥电议型 号：T20760产 地：中国大陆
-
T2054AltiratinibDCC-2701
Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
价 格：￥电议型 号：T2054产 地：中国大陆
-
T10652VimseltinibDCC-3014
DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10).
价 格：￥电议型 号：T10652产 地：中国大陆
-
T2054AltiratinibAltiratinib,DCC-2701,
Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
价 格：￥电议型 号：T2054产 地：美洲
-
T2640DCC-2036DCC-2036,DCC2036,DCC 2036
DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit.
价 格：￥电议型 号：T2640产 地：美洲
-
T8482Ripretinib；瑞普替尼DCC-2618；DCC-2618|||瑞普替尼
Ripretinib (DCC-2618) is an orally bioavailable inhibitor of KIT and PDGFRA.
价 格：￥电议型 号：T8482产 地：中国大陆
-
T4332c-Kit-IN-1；化合物c-Kit-IN-1PDGFR inhibitor 1|||DCC-2618；PDGFR inhibitor 1|||DCC-2618
c-Kit-IN-1 (DCC-2618) is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).
价 格：￥电议型 号：T4332产 地：中国大陆
-
T2640Rebastinib；化合物DCC-2036DCC2036|||DCC 2036|||DCC-2036；DCC2036|||DCC 2036|||DCC-2036
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.
价 格：￥电议型 号：T2640产 地：中国大陆
-
T25292DCCCyb；化合物 T25292DCCCyb
DCCCyb is an orally bioavailable and selective GlyT1 Inhibitor. DCCCyb demonstrated excellent in vivo occupancy of GlyT1 transporters in rhesus monkeys as determined by the displacement of a PET tracer ligand.
价 格：￥电议型 号：T25292产 地：中国大陆
-
T20760Benzidine orange；颜料橙13DCC-1802|||Polymo Orange GR|||Oralith Orange PG|||DCC 1802|||DCC1802；DCC-1802|
Benzidine orange (DCC-1802) shows mutagenic and carcinogenic activity.
价 格：￥电议型 号：T20760产 地：中国大陆
-
T2054Altiratinib；化合物AltiratinibDCC-2701；DCC-2701
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
价 格：￥电议型 号：T2054产 地：中国大陆
-
T19946DCC Crosslinker；化合物 T19946DCC Cross-linker|||Cyclohexaamine；DCC Cross-linker|||Cyclohexaamine
DCC Crosslinker is a zero-length crosslinker. DCC crosslinker is commonly used in the synthesis of active ester-containing reagents.
价 格：￥电议型 号：T19946产 地：中国大陆
-
T10652Vimseltinib；化合物DCC-3014DCC-3014；DCC-3014
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM).
价 格：￥电议型 号：T10652产 地：中国大陆
